Arrowhead Pharmaceuticals
ARWR
#1823
Rank
A$17.03 B
Marketcap
A$120.97
Share price
4.41%
Change (1 day)
372.30%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): A$0.55 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$1.09 Billion. , an increase over its 2024 earnings that were of -A$0.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 A$0.49 B-157.5%
2024 -A$0.87 Billion112.45%
2023 -A$0.41 Billion87.79%
2022 -A$0.22 Billion-20.1%
2021 -A$0.28 Billion67.59%
2020 -A$0.17 Billion-347.53%
2019 A$65.37 M-245.59%
2018 -A$44.91 Million-13.17%
2017 -A$51.72 Million-52.28%
2016 -A$0.11 Billion-16.57%
2015 -A$0.13 Billion30.32%
2014 -A$99.69 Million171.62%
2013 -A$36.7 Million16.56%
2012 -A$31.49 Million107.53%
2011 -A$15.18 Million
2008 -A$53.45 Million-8.07%
2007 -A$58.14 Million70.37%
2006 -A$34.13 Million122.51%
2005 -A$15.34 Million147.41%
2004 -A$6.2 Million2002.28%
2003 -A$0.3 Million-85.61%
2002 -A$2.05 Million1371.97%
2001 -A$0.14 Million-13.45%
2000 -A$0.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.41 B 7,427.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.49 Billion-1,001.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.23 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.25 B 151.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-A$0.16 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA